Various endocrine therapy strategies, including SERD, SERM, AI, GnRHa, and inhibitors of PI3K, AKT, mTOR, and CDK4/6, are being explored to enhance the immune response in breast cancer (146). The gene discussed is AKT1; the disease is breast carcinoma.